Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Cash from Investing Activities (2021 - 2026)

Prokidney's (PROK) quarterly Cash from Investing Activities came in at $12.8 million in Q2 2026, down 31.02% year-over-year from $18.6 million in Q2 2025, and down 63.23% quarter-over-quarter from $34.8 million in Q1 2026.

Analysis

Prokidney (PROK) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Cash from Investing Activities for 6 consecutive years, with $12.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 31.02% year-over-year to $12.8 million in Q2 2026; TTM through Jun 2026 was $104.7 million, a 631.67% increase from a year earlier, with the FY2025 full-year figure at $104.0 million, up 409.28% from the prior year.
  • Cash from Investing Activities was $12.8 million for Q2 2026 at Prokidney, down from $34.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $58.4 million in Q1 2024 and troughed at -$192.6 million in Q1 2023.
  • A 5-year average of -$8.9 million and a median of $6.3 million in 2022 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities tumbled 31221.57% in 2023 and soared 317.21% in 2024, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$306000.0 in 2022, then plunged by 31221.57% to -$95.8 million in 2023, then jumped by 115.73% to $15.1 million in 2024, then surged by 86.29% to $28.1 million in 2025, then sank by 54.42% to $12.8 million in 2026.
  • The last three Cash from Investing Activities figures came in at $12.8 million (Q2 2026), $34.8 million (Q1 2026), and $28.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -161.58 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -55.66 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -74.05 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -120.00 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 53.26 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -9.88 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 26.69 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -93.37 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -2.82 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 12.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.81 Mn
Mar 31, 2026 34.83 Mn
Dec 31, 2025 28.09 Mn
Sep 30, 2025 29.02 Mn
Jun 30, 2025 18.57 Mn
Mar 31, 2025 28.29 Mn
Dec 31, 2024 15.08 Mn
Sep 30, 2024 -81.64 Mn
Jun 30, 2024 28.57 Mn
Mar 31, 2024 58.40 Mn
Dec 31, 2023 -95.84 Mn
Sep 30, 2023 -28.37 Mn
Jun 30, 2023 -13.15 Mn
Mar 31, 2023 -192.61 Mn
Dec 31, 2022 -306,000.00
Sep 30, 2022 -207,000.00
Jun 30, 2022 -386,000.00
Mar 31, 2022 -839,000.00
Dec 31, 2021 -250.00 Mn
Sep 30, 2021 -250.00 Mn